Xilio Therapeutics, Inc. (XLO)
NASDAQ: XLO · Real-Time Price · USD
7.66
-0.26 (-3.28%)
Apr 29, 2026, 1:18 PM EDT - Market open
Xilio Therapeutics Employees
Xilio Therapeutics had 76 employees as of December 31, 2025. The number of employees increased by 12 or 18.75% compared to the previous year.
Employees
76
Change (1Y)
12
Growth (1Y)
18.75%
Revenue / Employee
$575,868
Profits / Employee
-$461,000
Market Cap
44.29M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 76 | 12 | 18.75% |
| Dec 31, 2024 | 64 | -9 | -12.33% |
| Dec 31, 2023 | 73 | -16 | -17.98% |
| Dec 31, 2022 | 89 | 15 | 20.27% |
| Dec 31, 2021 | 74 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Mereo BioPharma Group | 39 |
| Plus Therapeutics | 28 |
| Atossa Therapeutics | 16 |
| Rallybio | 14 |
| Nutriband | 13 |
| Hyperion DeFi | 9 |
| Dogwood Therapeutics | 8 |
| Lite Strategy | 4 |
XLO News
- 11 days ago - Xilio Therapeutics Announces New Preclinical Data at AACR Annual Meeting for XTX601, a Masked T Cell Engager Targeting CLDN18.2 - GlobeNewsWire
- 13 days ago - Xilio Therapeutics Appoints Cheryl R. Blanchard, Ph.D. - GlobeNewsWire
- 25 days ago - Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 5 weeks ago - Xilio Therapeutics Announces Pipeline and Business Updates and Fourth Quarter and Full Year 2025 Financial Results - GlobeNewsWire
- 6 weeks ago - Xilio Therapeutics to Present New Preclinical Data for its Masked T Cell Engager Program Targeting CLDN18.2 at the American Association for Cancer Research (AACR) Annual Meeting - GlobeNewsWire
- 6 weeks ago - Xilio Therapeutics Announces 1-for-14 Reverse Stock Split - GlobeNewsWire
- 7 weeks ago - Xilio Therapeutics Transcript: Leerink Global Healthcare Conference 2026 - Transcripts
- 2 months ago - Xilio Therapeutics to Present at the Leerink Partners Global Healthcare Conference - GlobeNewsWire